1 H and 13 C NMR spectra were recorded on a Varian AS 300 or 400 spectrometer.
A portion of the thus obtained phosphonium salts (5 mmol) was suspended in CH 2 Cl 2 (10 mL) in a separatory funnel. 2 M aq. KOH (4 mL) was added, and the biphasic mixture vigorously shaken for a few minutes. H 2 O (ca 10 mL) and CH 2 Cl 2 (ca 10 mL) were then added, the two phases separated, and the aqueous phase extracted with CH 2 Cl 2 . The combined organic phases were dried over MgSO 4 , filtered and evaporated under reduced pressure, giving the corresponding ylides 2i and 2j as white foams in 75-90% yield. These ylides were used in the catalytic reaction without further purification, and could be stored in a freezer (-20 °C) for several months without apparent decomposition. 1 H NMR data for tert-butyl 2-(tris(4-methoxyphenyl)phosphoranylidene)acetate 7. 66-7.48 (m, 6H), 6.99-6.86 (m, 6H) 
General procedure for the optimized catalytic asymmetric Wittig reaction.
In a vial, (R,R)-TADDOL 4g (14.0 mg, 0.030 mmol, 20 mol%) and ketone 1a-e (0.45 mmol, 3 equiv.) were dissolved in toluene (0.75 mL). To the resulting solution, cooled to 0 °C, ylide 2i (70 mg, 0.15 mmol) was added in one portion. The vial was carefully capped, and the reaction mixture was let standing in an ice bath in a fridge (0 °C) without stirring and without precautions to exclude moisture or air. After 144 h, the product was directly obtained by chromatography on silica gel (n-hexane/Et 2 O 97.5:2.5, then 95:5).
tert-Butyl 2-(4-(tert-butyl)cyclohexylidene)acetate (3c).
Following the general procedure, the title compound was obtained as an oil in 74% yield. The enantiomeric excess of the product was determined by chiral stationary phase HPLC (Chiralcel OD, n-hexane/i-PrOH 99.9:0.1, 1 mL/min, λ 215 nm, t maj = 6.4 min, t min = 4.9 min, 70% ee 
tert-Butyl 2-(4-isopropylcyclohexylidene)acetate (3i).
Following the general procedure, the title compound was obtained as an oil in 76% yield. The enantiomeric excess of the product was determined by chiral stationary phase HPLC (Chiralcel OD, n-hexane/i-PrOH 99.9:0.1, 1 mL/min, λ 215 nm, t maj = 5.3 min, t min = 4.6 min, 59% ee COOt -Bu H
tert-Butyl 2-(4-propylcyclohexylidene)acetate (3j).
Following the general procedure, the title compound was obtained as an oil in 76% yield.
The enantiomeric excess of the product was determined by chiral stationary phase HPLC (Chiralcel OD, n-hexane/i-PrOH 99.9:0.1, 1 mL/min, λ 215 nm, t maj = 4.9 min, t min = 4.6 min, 64% ee 
tert-Butyl 2-(4-methylcyclohexylidene)acetate (3k).
Following the general procedure, the title compound was obtained as an oil in 83% yield. 6, 161.7, 115.0, 79.7, 37.5, 36.7, 35.9, 32.5, 29.0, 28.5, 21.9 . GC-MS m/z 154 (100, -isobutene, McLafferty rearrangement), 137 (47, -Ot-Bu), 57 (75, t-Bu + ).
COOt -Bu H COOt -Bu H

Benzyl 2-(4-methylcyclohexylidene)acetate (3l).
Following the general procedure, using ylide 2j and performing the reaction in a toluene-nhexane 1:3 mixture, the title compound was obtained as a thick oil in 41% yield. The enantiomeric excess of the product was determined by chiral stationary phase HPLC (Chiralcel OB-H, n-hexane/i-PrOH 99:1, 0.75 mL/min, λ 254 nm, t maj = 12.4 min, t min = 14.5 min, 56% ee). (t, J = 6.6 Hz, 3H). 13 C NMR (CDCl 3 , 100 MHz) δ 166. 7, 164.4, 136.7, 128.7, 128.3, 128.2, 113.0, 65.6, 37.6, 36.7, 36.0, 32.4, 29.3, 21.8 . GC-MS m/z 244 (3, M + ), 153 (18, -Bn), 137 (15, -OBn), 91 (100, C 7 H 7 + ). 
tert-Butyl 2-(4-phenylcyclohexylidene)acetate (3m).
Following the general procedure, the title compound was obtained as a thick oil in 93% yield.
The enantiomeric excess of the product was determined by chiral stationary phase HPLC (Chiralcel OD, n-hexane/i-PrOH 99.9:0.1, 1.0 mL/min, λ 215 nm, t maj = 13.3 min, t min = 11.1 min, 67% ee 6, 160.4, 146.4, 128.6, 127.0, 126.4, 115.7, 79.9, 44.4, 37.8, 35.8, 35.0, 29.4, 28.5 
